How many patents does
B.R.A.H.M.S have?
patents
709
families
89
granted
207
applications
502
US
175
EP
145
CN
102
JP
65
WO
56
GB
1
RoW
165
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
B.R.A.H.M.S
Top ten assignees appearing on patents
2009 - 2018
| b.r.a.h.m.s | 571 |
| holsboermaschmeyer neurochemie | 4 |
| bioassays | 4 |
| sanko junyaku | 3 |
| brahms ag (de) | 2 |
| eisai r&d management company | 2 |
| sphingo tec | 1 |
| ge medical | 1 |
| adrenomed | 1 |
| sanko junyaku co., | 1 |
2009
| b.r.a.h.m.s | 71 |
| bioassays | 3 |
2018
| b.r.a.h.m.s | 30 |
B.R.A.H.M.S
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| use of procalcitonin (pct) in risk stratification and prognosis of patients with a prima… 🛈 | 41 | 2007 |
| procalcitonin 3-116 | 19 | 1998 |
| diagnosis and risk stratification using nt-proet-1 | 19 | 2007 |
| diagnosis and risk stratification of infections and chronic diseases of the respiratory … 🛈 | 18 | 2006 |
| prognostic biomarkers for the progression of primary chronic kidney disease | 18 | 2008 |
| biomarkers for the prediction of incident cancer | 18 | 2010 |
| molecular markers for urinary tract infections | 17 | 2010 |
| prediction of outcome in patients with chronic obstructive pulmonary disease | 17 | 2012 |
| prognosis of adverse events in patients with suspected chronic heart failure | 16 | 2012 |
| risk stratification for acute coronary syndrome by means of fragments/partial peptides o… 🛈 | 16 | 2006 |